LeonaBio (LONA) Net Cash Flow (2019 - 2026)
LeonaBio (LONA) posted quarterly Net Cash Flow of -$36.4 million for Q1 2026, down 65.53% year-over-year from -$105.7 million in Q1 2025, and down 175.29% quarter-over-quarter from $48.4 million in Q4 2025.
LeonaBio (LONA) Net Cash Flow (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Net Cash Flow for 8 consecutive years, with -$36.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 65.53% year-over-year to -$36.4 million; the TTM figure through Mar 2026 stood at $6.4 million (up 112.39% YoY), while the FY2025 annual figure was $20.8 million, up 149.44% from the prior year.
- Net Cash Flow declined to -$36.4 million in Q1 2026 per LONA's latest filing, from $48.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $48.4 million in Q4 2025 and bottomed at -$36.4 million in Q1 2026.
- Historically, Net Cash Flow has averaged -$4.5 million across 5 years, with a median of -$5.0 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow tumbled 686.75% — and 2025, when it jumped 268.12%.
- LeonaBio's Net Cash Flow stood at $9.1 million in 2022, then tumbled by 316.39% to -$19.8 million in 2023, then slumped by 45.78% to -$28.8 million in 2024, then surged by 268.12% to $48.4 million in 2025, then plunged by 175.29% to -$36.4 million in 2026.
- Business Quant data shows LONA's Net Cash Flow at -$36.4 million in Q1 2026, $48.4 million in Q4 2025, and $986000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | -624,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.44 Mn |
| Mar 31, 2026 | -36.44 Mn |
| Dec 31, 2025 | 48.40 Mn |
| Dec 31, 2025 | 48.40 Mn |
| Sep 30, 2025 | 986,000.00 |
| Sep 30, 2025 | 986,000.00 |
| Jun 30, 2025 | -6.56 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | -22.02 Mn |
| Mar 31, 2025 | -22.02 Mn |
| Dec 31, 2024 | -28.79 Mn |
| Dec 31, 2024 | -28.79 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | 4.23 Mn |
| Jun 30, 2024 | 4.23 Mn |
| Mar 31, 2024 | -12.76 Mn |
| Mar 31, 2024 | -12.76 Mn |
| Dec 31, 2023 | -19.75 Mn |
| Dec 31, 2023 | -19.75 Mn |